The first year of respiratory syncytial virus (RSV) surveillance in Tasmania,1 July 2022-30 June 2023

被引:0
作者
McPherson, Michelle [1 ]
Stephens, Nicola [1 ]
Yadav, Bhavika [1 ]
Melody, Shannon [2 ]
机构
[1] Univ Tasmania, Tasmanian Sch Med, Hobart, Tas, Australia
[2] Dept Hlth, Publ Hlth Serv, Hobart, Tas, Australia
关键词
respiratory syncytial virus; RSV; surveillance; Tasmania;
D O I
10.33321/cdi.2025.49.040
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Respiratory syncytial virus (RSV) became notifiable in Tasmania on 1 July 2022. This study describes the epidemiology and data quality of all notifications of laboratory confirmed RSV that had a specimen collection date from 1 July 2022 to 30 June 2023 in Tasmania. Descriptive analysis was undertaken by age group, sex, month of notification and residential location; data quality was assessed through completeness of reporting. There were 4,491 notifications of RSV in Tasmania, equating to a notification rate of 779 per 100,000 population per year. The highest proportion of RSV notifications were in children, there was a seasonal increase during winter and higher notification rates in the North region. Data completeness was greater than 98% for most person, place and time variables. This analysis of RSV notifications provides a baseline for the ongoing surveillance of RSV in Tasmania.
引用
收藏
页数:9
相关论文
共 11 条
[1]  
Australian Technical Advisory Group on Immunisation (ATAGI), 2024, Australian Immunisation Handbook
[2]   The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in Australia [J].
Brusco, Natasha K. ;
Alafaci, Annette ;
Tuckerman, Jane ;
Frawley, Helena ;
Pratt, Jeremy ;
Daley, Andrew J. ;
Todd, Angela K. ;
Deng, Yi-Mo ;
Subbarao, Kanta ;
Barr, Ian ;
Crawford, Nigel W. .
COMMUNICABLE DISEASES INTELLIGENCE, 2022, 46
[3]  
Communicable Diseases Network of Australia (CDNA), 2022, Respiratory syncytial virus-Surveillance case definition
[4]   RSV Prevention in All Infants: Which Is the Most Preferable Strategy? [J].
Esposito, Susanna ;
Abu Raya, Bahaa ;
Baraldi, Eugenio ;
Flanagan, Katie ;
Martinon Torres, Federico ;
Tsolia, Maria ;
Zielen, Stefan .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[5]   Burden of respiratory syncytial virus disease across the lifespan in Australia and New Zealand: a scoping review [J].
Farquharson, K. A. ;
Anthony, D. ;
Menzies, R. ;
Homaira, N. .
PUBLIC HEALTH, 2024, 226 :8-16
[6]   Developing a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia [J].
Gebremedhin, Amanuel Tesfay ;
Hogan, Alexandra B. ;
Blyth, Christopher C. ;
Glass, Kathryn ;
Moore, Hannah C. .
SCIENTIFIC REPORTS, 2022, 12 (01)
[7]   Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods [J].
Gibbons, Cheryl L. ;
Mangen, Marie-Josee J. ;
Plass, Dietrich ;
Havelaar, Arie H. ;
Brooke, Russell John ;
Kramarz, Piotr ;
Peterson, Karen L. ;
Stuurman, Anke L. ;
Cassini, Alessandro ;
Fevre, Eric M. ;
Kretzschmar, Mirjam E. E. .
BMC PUBLIC HEALTH, 2014, 14
[8]   Respiratory syncytial virus-associated hospitalisations in Australia, 2006-2015 [J].
Saravanos, Gemma L. ;
Sheel, Meru ;
Homaira, Nusrat ;
Dey, Aditi ;
Brown, Edward ;
Wang, Han ;
Macartney, Kristine ;
Wood, Nicholas J. .
MEDICAL JOURNAL OF AUSTRALIA, 2019, 210 (10) :447-453
[9]   Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis [J].
Savic, Miloje ;
Penders, Yolanda ;
Shi, Ting ;
Branche, Angela ;
Pircon, Jean-Yves .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (01)
[10]   Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants [J].
Stiboy, Eunice ;
Chan, Mei ;
Islam, Md Saiful ;
Saravanos, Gemma L. ;
Lui, Kei ;
Jaffe, Adam ;
Homaira, Nusrat .
PEDIATRIC PULMONOLOGY, 2023, 58 (04) :1210-1220